An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma

Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive tumors with an extremely low 5-year survival rate. Accumulating evidence has unveiled that inflammatory response promotes tumor progression, enhances angiogenesis, and causes local immunosuppression. Herein, we aim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zhijun, Li, Jinyin, Yu, Qian, Zhou, Ting, Duan, Jingjing, Yang, Zhen, Liu, Cuicui, Xu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733666/
https://www.ncbi.nlm.nih.gov/pubmed/35002712
http://dx.doi.org/10.3389/fphar.2021.778294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733666/
https://www.ncbi.nlm.nih.gov/pubmed/35002712
http://dx.doi.org/10.3389/fphar.2021.778294

Ejemplares similares